Cite
HARVARD Citation
Hawkins, N. et al. (2021). Soticlestat, a novel cholesterol 24‐hydroxylase inhibitor, reduces seizures and premature death in Dravet syndrome mice. Epilepsia. pp. 2845-2857. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Hawkins, N. et al. (2021). Soticlestat, a novel cholesterol 24‐hydroxylase inhibitor, reduces seizures and premature death in Dravet syndrome mice. Epilepsia. pp. 2845-2857. [Online].